The Found Script
Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.
Browse all articles A–Z →
Insulin Aspart Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on the Insulin Aspart (NovoLog/Fiasp) shortage in 2026: timeline, prescribing implications, alternatives, and patient resources.

Advair Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Advair availability in 2026: supply chain factors, prescribing implications, therapeutic alternatives, and patient access tools.

Clomiphene Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing for providers on Clomiphene (Clomid) availability in 2026 — supply chain status, prescribing implications, and patient access tools.

Breo Ellipta Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused update on Breo Ellipta availability in 2026 — covering supply status, prescribing implications, alternatives, and patient access tools.
40,000+ have already found their meds with Medfinder.
Stop calling pharmacies. Start your search today.

Loestrin Fe 1/20 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the Loestrin Fe 1/20 28 Day shortage in 2026: timeline, prescribing implications, alternatives, and tools to help your patients.

Clomipramine Shortage: What Providers and Prescribers Need to Know in 2026
A clinical briefing on the Clomipramine shortage for providers. Covers supply timeline, prescribing implications, alternatives, and tools to help patients.

Junel Fe 1.5/30 28 Day Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on the Junel Fe 1.5/30 28 Day shortage in 2026: timeline, prescribing implications, availability, costs, and tools to help your patients.

Buprenorphine/Naloxone Shortage: What Providers and Prescribers Need to Know in 2026
A provider-focused briefing on Buprenorphine/Naloxone supply in 2026: prescribing implications, availability, cost, and tools to support patient access.
Intrarosa shortage: What providers and prescribers need to know in 2026
A provider-focused update on Intrarosa availability in 2026. Learn about stocking issues, prescribing implications, alternatives, and tools to help patients.

Imipramine Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Imipramine availability in 2026. Covers shortage status, prescribing implications, alternatives, and tools to help patients.

How to Help Your Patients Save Money on Gabapentin: A Provider's Guide to Savings Programs
A provider guide to savings programs for Gabapentin in 2026, covering GoodRx, manufacturer programs, formulary strategies, and resources for underinsured patients.

Bronkaid Max Shortage: What Providers and Prescribers Need to Know in 2026
A provider briefing on Bronkaid Max availability in 2026: shortage timeline, prescribing implications, cost data, and tools to help patients.